Biggest News Aggregation in the World
๐Ÿ“ฐ Final Analysis News

Page 3 - Final Analysis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Final Analysis. Real-time updates on events, politics, business and more.

Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the final results from the randomized Phase 2 GRIFFIN study...
United States Bortezomib Melphalan Douglasw Sborov Velcade Melphalan Velcade Bortezomib Melphalan Imran Khan

Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma

Data featured in plenary session at the 19th International Myeloma Society Annual Meeting LOS ANGELES, Aug. 27, 2022 /PRNewswire/ -- The Janssen P...
United States Bortezomib Melphalan Douglasw Sborov Velcade Melphalan Velcade Bortezomib Melphalan Imran Khan

Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

10.05.2022 - New clinical results from MORNINGSKY trial shows 71% reduction in hospitalization (secondary endpoint) in broad patient population with COVID-19 treated with bemnifosbuvir (AT-527) versus placebo (p=0.047, unadjusted, exploratory) New clinical ...
United States Jean Pierre Sommadossi Jonae Barnes Founder Of Atea Pharmaceuticals Bemnifosbuvir Clinical Development Nature Communications

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science